Alpine Immune Sciences, Inc (ALPN)

Etorro trading 970x250
Alpine Immune Sciences, Inc (ALPN) Logo

About Alpine Immune Sciences, Inc

Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline include ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated autoimmune/inflammatory diseases. The company has a collaboration agreement with AbbVie Ireland Unlimited Company for the research, development, and commercialization of ALPN-101; and Adaptimmune Therapeutics plc to develop next-generation SPEAR T cell products. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington. Address: 188 East Blaine Street, Seattle, WA, United States, 98102

Alpine Immune Sciences, Inc News and around…

Latest news about Alpine Immune Sciences, Inc (ALPN) common stock and company :

Notable Two Hundred Day Moving Average Cross - ALPN
29 Nov, 2021 FinancialContent

In trading on Monday, shares of Alpine Immune Sciences Inc (ALPN) crossed below their 200 day moving average of $10.80, changing hands as low as $10.26 per share. Alpine Immune Sciences Inc shares are currently trading down about 8.9% on the day..

Alpine Immune Sciences Announces Participation in Fireside Chat at the 4th Annual Evercore ISI HealthCONx Conference
22 Nov, 2021 FinancialContent

Alpine Immune Sciences Announces Participation in Fireside Chat at the 4th Annual Evercore ISI HealthCONx Conference

Alpine Immune Sciences Provides Corporate Update and Reports Third Quarter 2021 Financial Results
10 Nov, 2021 FinancialContent

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today provided a corporate update and reported financial results for the third quarter ended September 30, 2021.

Alpine Immune Sciences to Present ALPN-303 Data at American College of Rheumatology Convergence 2021 Annual Meeting
08 Nov, 2021 FinancialContent

Alpine Immune Sciences to Present ALPN-303 Data at American College of Rheumatology Convergence 2021 Annual Meeting

Alpine Immune Sciences, Inc. (ALPN) Earnings Expected to Grow: What to Know Ahead of Q3 Release
04 Nov, 2021 Yahoo! Finance

Alpine Immune Sciences, Inc. (ALPN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Alpine Immune Sciences (NASDAQ:ALPN) jumps 12% this week, taking three-year gains to 96%
02 Oct, 2021 Yahoo! Finance

One simple way to benefit from the stock market is to buy an index fund. But if you pick the right individual stocks...

Alpine Immune Sciences, Inc. (ALPN) Surges 6.2%: Is This an Indication of Further Gains?
28 Sep, 2021 Yahoo! Finance

Alpine Immune Sciences, Inc. (ALPN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Notable Insider Buys Of The Past Week Include Designer Brands, MacroGenics And More
25 Sep, 2021 FinancialContent

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. The ...

Friday 9/24 Insider Buying Report: COMS, ALPN
24 Sep, 2021 FinancialContent

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.

3 Stocks Insiders Are Buying
24 Sep, 2021 FinancialContent

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. ...

50 Biggest Movers From Yesterday
23 Sep, 2021 FinancialContent

Gainers Marin Software Incorporated (NASDAQ: MRIN) shares jumped 61.9% to close at $9.21 on Wednesday following an announcement ...

12 Health Care Stocks Moving In Wednesday's After-Market Session
22 Sep, 2021 FinancialContent

Gainers Regencell Bioscience (NASDAQ:RGC) shares rose 21.54% to $25.1 during Wednesday's after-market session. ...

32 Stocks Moving In Wednesday's Mid-Day Session
22 Sep, 2021 FinancialContent

Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 53.1% to $8.71 following an announcement from management that ...

ALPN Makes Bullish Cross Above Critical Moving Average
22 Sep, 2021 FinancialContent

In trading on Wednesday, shares of Alpine Immune Sciences Inc (ALPN) crossed above their 200 day moving average of $11.05, changing hands as high as $11.88 per share. Alpine Immune Sciences Inc shares are currently trading up about 11.9% on the day..

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
22 Sep, 2021 FinancialContent

Gainers Aethlon Medical (NASDAQ:AEMD) shares rose 33.15% to $5.06 during Wednesday's pre-market session. The market ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
22 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We're halfway through the week and starting off Wednesday with a look at the biggest pre-market stock movers today. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

20 Stocks Moving in Wednesday's Pre-Market Session
22 Sep, 2021 FinancialContent

Gainers Marin Software Incorporated (NASDAQ: MRIN) rose 70.1% to $9.68 in pre-market trading following an announcement from ...

Alpine Immune Sciences Earnings Perspective: Return On Capital Employed
21 Sep, 2021 FinancialContent

Alpine Immune Sciences (NASDAQ:ALPN) brought in sales totaling $7.19 million during Q2 according to data provided by Benzinga Pro. ...

Alpine Immune Sciences Announces $91 Million Private Placement
15 Sep, 2021 FinancialContent

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced it has entered into a definitive securities purchase agreement for the sale of common stock and prefunded warrants, as described below, in a private placement with certain institutional and other accredited investors for gross proceeds to Alpine of approximately $91 million, before deducting offering expenses. The private placement is being led by Frazier Life Sciences Public Fund with participation from Decheng Capital, BVF Partners, TCG X, Avidity Partners, OrbiMed, Omega Fund, and Logos Capital, among others.

Alpine Immune Sciences Announces Participation in September Investor Conferences
07 Sep, 2021 FinancialContent

Alpine Immune Sciences Announces Participation in September Investor Conferences

Broker Revenue Forecasts For Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Are Surging Higher
18 Aug, 2021 Yahoo! Finance

Alpine Immune Sciences, Inc. ( NASDAQ:ALPN ) shareholders will have a reason to smile today, with the analysts making...

Alpine Immune Sciences, Inc. (ALPN) Reports Q2 Loss, Tops Revenue Estimates
10 Aug, 2021 Yahoo! Finance

Alpine Immune Sciences, Inc. (ALPN) delivered earnings and revenue surprises of -58.62% and 9.15%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Alpine Immune Sciences: Q2 Earnings Insights
10 Aug, 2021 FinancialContent

Shares of Alpine Immune Sciences (NASDAQ:ALPN) moved higher in after-market trading after the company reported Q2 results. Quarterly ...

Alpine Immune Sciences Provides Corporate Update and Reports Second Quarter 2021 Financial Results
10 Aug, 2021 FinancialContent

Alpine Immune Sciences Provides Corporate Update and Reports Second Quarter 2021 Financial Results

Earnings Scheduled For August 10, 2021
10 Aug, 2021 FinancialContent

Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its ...

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
08 Aug, 2021 FinancialContent

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader ...

Alpine Immune Sciences to Report Second Quarter 2021 Financial Results and to Present at Upcoming Investor Conferences
04 Aug, 2021 FinancialContent

Alpine Immune Sciences to Report Second Quarter 2021 Financial Results and to Present at Upcoming Investor Conferences

Will Alpine Immune Sciences, Inc. (ALPN) Report Negative Q2 Earnings? What You Should Know
03 Aug, 2021 Yahoo! Finance

Alpine Immune Sciences, Inc. (ALPN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Were Hedge Funds Right About Alpine Immune Sciences, Inc. (ALPN)?
30 Jul, 2021 Yahoo! Finance

In this article we are going to use hedge fund sentiment as a tool and determine whether Alpine Immune Sciences, Inc. (NASDAQ:ALPN) is a good investment right now. We like to analyze hedge fund sentiment before conducting days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy League […]

Read This Before Selling Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares
24 Jul, 2021 Yahoo! Finance

It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...

Alpine Immune Sciences, Inc (ALPN) is a NASDAQ Common Stock listed in , ,

970x250